{
  "data": {
    "indicator": {
      "slug": "ctgov-autoimmune-registered-trials",
      "name": "Registered interventional autoimmune cell therapy and T-cell engager trials",
      "definition": "Count of interventional studies of CAR-T, CAR-NK or T-cell-engager therapies in autoimmune conditions, excluding records that also list a cancer on ClinicalTrials.gov, any start date.",
      "unit": "count",
      "scale": "1",
      "default_unit": "count",
      "default_scale": "1"
    },
    "scale": "1",
    "unit": "count",
    "region": {
      "code": "GLOBAL",
      "name": "Global",
      "type": "world"
    },
    "points": [
      {
        "period_start": "2026-09-27",
        "period_label": "as of 27 Sep 2026",
        "value": 336,
        "scale": "1",
        "unit": "count",
        "value_type": "actual",
        "statistic_id": "stat_T092TP8T4XEAK9EF95GA0QHKB5",
        "url": "https://statorigin.org/stat/stat_T092TP8T4XEAK9EF95GA0QHKB5",
        "source_org": "ClinicalTrials.gov",
        "source": {
          "org": "ClinicalTrials.gov (U.S. National Library of Medicine)",
          "org_short_name": "ClinicalTrials.gov",
          "document_title": "ClinicalTrials.gov study count: All interventional studies of CAR-T, CAR-NK or T-cell-engager therapies in autoimmune conditions, excluding records that also list a cancer, any start date, as registered on 2026-09-27",
          "document_url": "https://clinicaltrials.gov/api/v2/studies?query.intr=%22CAR-T%22%20OR%20%22CAR%20T%22%20OR%20%22chimeric%20antigen%20receptor%22%20OR%20CAR-NK%20OR%20%22T%20cell%20engager%22%20OR%20blinatumomab%20OR%20teclistamab%20OR%20mosunetuzumab%20OR%20imvotamab&query.cond=lupus%20OR%20%22systemic%20sclerosis%22%20OR%20myasthenia%20OR%20%22multiple%20sclerosis%22%20OR%20myositis%20OR%20%22rheumatoid%20arthritis%22%20OR%20vasculitis%20OR%20autoimmune%20OR%20neuromyelitis%20OR%20Sjogren%20OR%20%22immune%20thrombocytopenia%22%20OR%20nephropathy%20OR%20pemphigus&filter.advanced=AREA%5BStudyType%5DINTERVENTIONAL%20AND%20NOT%20%28AREA%5BCondition%5Dcancer%20OR%20AREA%5BCondition%5Dtumor%20OR%20AREA%5BCondition%5Dneoplasm%20OR%20AREA%5BCondition%5Dcarcinoma%20OR%20AREA%5BCondition%5Dlymphoma%20OR%20AREA%5BCondition%5Dleukemia%20OR%20AREA%5BCondition%5Dmyeloma%20OR%20AREA%5BCondition%5Dmalignancy%29&countTotal=true&pageSize=1&fields=NCTId",
          "locator": "totalCount field of the API response. Query: All interventional studies of CAR-T, CAR-NK or T-cell-engager therapies in autoimmune conditions, excluding records that also list a cancer, any start date, as registered on 2026-09-27.",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "GLOBAL"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}